XML 72 R61.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Reporting - Schedule of Segment Profitability that are Most Relied Upon by the CODM are Gross Revenue and Net Income (Loss) (Details) - CODM [Member] - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Schedule of Segment Profitability that are Most Relied Upon by the Codm are Gross Revenue and Net Loss [Line Items]        
Revenue $ 50,821 $ 4,043 $ 93,026 $ 11,584
Operating Costs        
Compensation and benefits 50,285 5,411 138,451 14,247
Professional and consulting fees 1,440 499 4,066 1,917
Data processing 187 273 546 693
Other expenses 508 1,056 2,998 3,464
Income (loss) from operations (1,599) (3,196) (53,035) (8,737)
Other (expenses) income        
Interest income 550 280 973 729
Gain on marketable securities 159,130 89 163,094 767
Unrealized loss on note receivable (429) 221 (2,086)
Change in fair value of investments (32,000) (955) (6,445)
Total other (expenses) income 127,680 (1,015) 164,288 (7,035)
Net income (loss) 126,081 (4,211) 111,253 (15,772)
Less: Net income attributable to non-controlling interests 871   1,921  
Net income attributable to common stockholders of Dominari Holdings 125,210   109,332  
Total assets 223,446 43,431 223,446 43,431
Dominari Financial [Member]        
Schedule of Segment Profitability that are Most Relied Upon by the Codm are Gross Revenue and Net Loss [Line Items]        
Revenue 50,150 3,684 92,355 10,553
Operating Costs        
Compensation and benefits 41,025 3,798 78,455 10,037
Professional and consulting fees 255 232 1,613 993
Data processing 187 241 546 616
Other expenses (58) 167 675 1,697
Income (loss) from operations 8,741 (754) 11,066 (2,790)
Other (expenses) income        
Interest income 497 204 878 545
Gain on marketable securities 1,213 4,539
Unrealized loss on note receivable
Change in fair value of investments
Total other (expenses) income 1,710 204 5,417 545
Net income (loss) 10,451 (550) 16,483 (2,245)
Less: Net income attributable to non-controlling interests 871   1,921  
Net income attributable to common stockholders of Dominari Holdings 9,580   14,562  
Total assets 83,124 16,062 83,124 16,062
Legacy AIkido Pharma [Member]        
Schedule of Segment Profitability that are Most Relied Upon by the Codm are Gross Revenue and Net Loss [Line Items]        
Revenue 671 359 671 1,031
Operating Costs        
Compensation and benefits 9,260 1,613 59,996 4,210
Professional and consulting fees 1,185 267 2,453 924
Data processing 32 77
Other expenses 566 889 2,323 1,767
Income (loss) from operations (10,340) (2,442) (64,101) (5,947)
Other (expenses) income        
Interest income 53 76 95 184
Gain on marketable securities 157,917 89 158,555 767
Unrealized loss on note receivable (429) 221 (2,086)
Change in fair value of investments (32,000) (955) (6,445)
Total other (expenses) income 125,970 (1,219) 158,871 (7,580)
Net income (loss) 115,630 (3,661) 94,770 (13,527)
Less: Net income attributable to non-controlling interests    
Net income attributable to common stockholders of Dominari Holdings 115,630   94,770  
Total assets $ 140,322 $ 27,369 $ 140,322 $ 27,369